[Federal Register Volume 61, Number 182 (Wednesday, September 18, 1996)] [Notices] [Pages 49145-49147] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-23863] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [INFO-96-26] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information [[Page 49146]] on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Wilma Johnson, CDC Reports Clearance Officer, 1600 Clifton Road, MS- D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice. Proposed Projects 1. List of Ingredients Added to Tobacco in the Manufacture of Smokeless Tobacco Products--(0920-0338)--Extension--Oral use of smokeless tobacco represents a significant health risk which can cause cancer and a number of noncancerous oral conditions, and can lead to nicotine addiction and dependence. Furthermore, smokeless tobacco use is not a safe substitute for cigarette smoking. The Centers for Disease Control and Prevention's (CDC) Office on Smoking and Health (OSH) has been delegated the authority for implementing major components of the Department of Health and Human Services' (HHS) tobacco and health program, including collection of tobacco ingredients information. HHS's overall goal is to reduce death and disability resulting from cigarette smoking and other forms of tobacco use through programs of information, education and research. The Comprehensive Smokeless Tobacco Health Education Act of 1986 (15 U.S.C. 4401 et seq., Pub.L. 99-252) requires each person who manufactures, packages, or imports smokeless tobacco products to provide the Secretary of HHS with a list of ingredients added to tobacco in the manufacture of smokeless tobacco products. HHS is authorized to undertake research, and to report to the Congress (as deemed appropriate), on the health effects of the ingredients. The total cost to respondents is estimated at $22,000. ---------------------------------------------------------------------------------------------------------------- No. of Average burden/ Respondents No. of responses/ response (in Total burden respondents respondent hrs.) (in hrs.) ---------------------------------------------------------------------------------------------------------------- Tobacco manufacturers........................... 11 1 26 286 --------------------------------------------------------------- Total..................................... .............. .............. .............. 286 ---------------------------------------------------------------------------------------------------------------- 2. Survey of diagnostic and management practices for group A streptococcal pharyngitis--New--Appropriate diagnosis and management of streptococcal pharyngitis is important to prevent severe nonsuppurative complications such as rheumatic fever. In addition, early treatment will prevent suppurative complications and decrease spread of infection to close contacts. To achieve optimal sensitivity, the American Academy of Pediatrics recommends that throat cultures be performed, or that if an antigen detection test is done, that a negative test be backed-up by culture. Despite these recommendations, many clinicians diagnose streptococcal pharyngitis based on clinical findings or on the results of an antigen detection test alone. One factor that has been shown to be associated with the use of culture for diagnosis, is whether the physician cultures for group A streptococci in the office. Recent changes in the medical care system and in Federal regulations may have affected the availability and use of throat cultures in office settings. Managed care organizations are unlikely to reimburse clinicians for performing two diagnostic tests and, in a capitated system, any use of diagnostic testing would reduce a physician's profit. Moreover, recently implemented CLIA regulations of office laboratories may have decreased the use of office culture as physicians find it easier not to test than to comply with these regulations. Surveying physician diagnostic and management practices for group A streptococcal pharyngitis will help identify current practices and the factors that have affected the use of diagnostic testing, especially throat culture. These results can be used to develop interventions to promote appropriate diagnostic methods, leading to improved accuracy of diagnosis, and prevention of morbidity. This proposed two year study, will collect data from practicing pediatricians and family physicians on the characteristics of their practice, their approach to diagnosis of pharyngitis including the use of laboratory testing, the testing methods that are used in their office laboratory, recent changes that they have made in testing, and reasons for those changes. This survey will build on results of a survey that was conducted in 1991 before the implementation of CLIA regulations and the expansion of managed care. The survey will be carried out during the winter of 1996-97, in the Chicago metropolitan area by the Chairman of the American Academy of Pediatrics Section on Infectious Diseases, who also is an expert on streptococcal infections. Data will be entered and analyzed by this investigator in collaboration with CDC and the HCFA Region V office in Chicago. The total cost to respondents is estimated at $33,350. ---------------------------------------------------------------------------------------------------------------- No. of Avg. burden/ Respondents No. of responses/ response (in Total burden respondents respondent hrs.) (in hrs.) ---------------------------------------------------------------------------------------------------------------- Pediatricians and Family Physicians with primary care practices................................. 2000 1 0.333 667 --------------------------------------------------------------- Total..................................... .............. .............. .............. 677 ---------------------------------------------------------------------------------------------------------------- 3. Sentinel Surveillance for Chronic Liver Disease--New-- A questionnaire has been designed to collect information for the Sentinel Surveillance for Chronic Liver Disease project. The purpose of the project is to determine the incidence and period prevalence of physician-diagnosed chronic liver disease in a defined geographic area, the contribution of chronic viral hepatitis to the burden of disease, and the influence of etiologic agents(s) and other factors on mortality, and to monitor the incidence of and mortality from chronic lever disease over time. The information gathered will be analyzed, in conjunction with data collected from other sources, to address these questions. The results of the project will assist the Hepatitis Branch, Division of Viral and Rickettsial Diseases, National [[Page 49147]] Center for Infectious Diseases in accomplishing the part of its mission related to preparing recommendations for the prevention and control of all types of viral hepatitis and their sequellae. In order to focus prevention efforts and resource allocation, a representative view of the overall burden of chronic liver disease, its natural history, and the relative contribution of viral hepatitis is needed. The total cost to respondents is estimated at $600. ---------------------------------------------------------------------------------------------------------------- No. of Average burden/ Respondents No. of responses/ response (in Total burden respondents respondent hrs.) (in hrs.) ---------------------------------------------------------------------------------------------------------------- All consenting adults with physician- diagnosed chronic liver disease residing in catchment area........................................... 120 1 0.50 60 --------------------------------------------------------------- Total..................................... .............. .............. .............. 60 ---------------------------------------------------------------------------------------------------------------- Dated: September 12, 1996. Wilma G. Johnson, Acting Associate Director for Policy Planning and Evaluation Centers for Disease Control and Prevention (CDC). [FR Doc. 96-23863 Filed 9-17 -96; 8:45 am] BILLING CODE 4163-18-P